Gu Dian-Na, Huang Qian, Tian Ling
Shanghai Jiao Tong University School of Medicine, Shanghai First People's Hospital, Experimental Research Center , Shanghai 201620 , PR China +86 21 37798755 ; +86 21 37798276 ;
Expert Opin Ther Targets. 2015 Mar;19(3):415-26. doi: 10.1517/14728222.2014.988708. Epub 2014 Nov 29.
Increasing evidence supports that microRNAs (miRNAs) play crucial roles in cancer through post-transcriptional gene silencing of their target genes, therefore, more and more effort has been devoted to develop miRNA-targeting therapeutics in cancer. MicroRNA-7 (miR-7) has been characterized as a potential tumor suppressor and regulates diverse fundamental biological processes of cancer cells including initiation, proliferation, migration, invasion, survival and death by targeting a number of oncogenic signaling pathways.
This review examines evidence of the biological responses of miR-7 in cancer, with an emphasis on its regulation of the vital oncogenic signaling pathways. It also discusses the rationale, strategies and challenges of miR-7 as a potential therapeutic target for cancer.
With the increasing understanding of molecular mechanisms of miR-7-mediated regulatory networks and the advancement of miRNA-based therapeutics, targeting miR-7 may be a potential and promising strategy for cancer therapy.
越来越多的证据支持,微小RNA(miRNA)通过对其靶基因进行转录后基因沉默在癌症中发挥关键作用,因此,人们越来越致力于开发针对癌症的miRNA靶向疗法。微小RNA-7(miR-7)已被确定为一种潜在的肿瘤抑制因子,并通过靶向多种致癌信号通路来调节癌细胞的多种基本生物学过程,包括起始、增殖、迁移、侵袭、存活和死亡。
本综述研究了miR-7在癌症中的生物学反应证据,重点关注其对重要致癌信号通路的调控。它还讨论了将miR-7作为癌症潜在治疗靶点的基本原理、策略和挑战。
随着对miR-7介导的调控网络分子机制的理解不断加深以及基于miRNA的治疗方法的进步,靶向miR-7可能是一种潜在且有前景的癌症治疗策略。